Periscope Capital’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-79,150
Closed -$780K 1261
2022
Q1
$780K Buy
+79,150
New +$780K 0.02% 631